High-dose intravenous metoprolol usage for reducing heart rate at CT coronary angiography: Efficacy and safety
Creators
- 1. Radiology Department, Plymouth Hospitals NHS Trust, Plymouth, Devon PL6 8DH (United Kingdom)
- 2. Cardiology Department, Musgrove Park Hospital, Taunton, Somerset TA1 5DA (United Kingdom)
- 3. Cardiology Department, Plymouth Hospitals NHS Trust, Plymouth, Devon PL6 8DH (United Kingdom)
- 4. Radiology Department, Royal Free Hospital, London NW3 2QG (United Kingdom)
Description
Aim: To evaluate the usage, safety, and efficacy of high-dose intravenous metoprolol for heart rate reduction in computer tomographic (CT) coronary angiography. Materials and methods: As this was retrospective analysis of anonymous data, medical ethics committee approval was waived by the regional health research authority. Patients, who had known iodinated contrast medium allergy, contraindications to β-blockers, atrial fibrillation, and indications other than suspected coronary artery disease, were excluded from analysis. The ultimate study population of 662 were analysed with details of intravenous metoprolol doses, complications, heart rate before administration of intravenous metoprolol (resting heart rate, RHR), heart rate at acquisition of scan (acquisition heart rate, AHR), and usage of low radiation dose protocols. Results: Of the ultimate study population of 662 patients, 183 had no intravenous metoprolol with mean acquisition heart rate (AHR) of 58 beats per minute (bpm), 257 had 1–15 mg intravenous metoprolol with mean AHR of 57 bpm, 114 had 16–29 mg intravenous metoprolol with mean AHR of 62 bpm and 108 had ≥30 mg intravenous metoprolol with mean AHR of 66 bpm. In the group receiving intravenous metoprolol, average usage was 19 mg (maximum 67 mg) with average reduction in HR of 15 bpm. There were no clinical incidents in relation to the use of high-dose intravenous metoprolol. Conclusion: Higher doses of intravenous metoprolol are beneficial in achieving target heart rates to facilitate usage of low radiation dose protocols. With appropriate exclusion criteria, higher doses of intravenous metoprolol, well in excess of 15 mg, can be safely administered when carefully titrated. - Highlights: • We evaluate intravenous metoprolol usage in a mature cardiac CT imaging service. • Intravenous metoprolol is beneficial to achieve lower heart rates for CTCA. • IV metoprolol doses in excess of 15 mg is efficacious and safe with careful titration
Availability note (English)
Available from http://dx.doi.org/10.1016/j.crad.2014.03.003Additional details
Identifiers
- DOI
- 10.1016/j.crad.2014.03.003;
- PII
- S0009-9260(14)00103-2;
Publishing Information
- Journal Title
- Clinical Radiology
- Journal Volume
- 69
- Journal Issue
- 7
- Journal Page Range
- p. 739-744
- ISSN
- 0009-9260
- CODEN
- CLRAAG
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46120161
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ALLERGY; BIOMEDICAL RADIOGRAPHY; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; CORONARIES; ETHICAL ASPECTS; HEART; PATIENTS; RADIATION DOSES
- Descriptors DEC
- ARTERIES; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DIAGNOSTIC TECHNIQUES; DOSES; MEDICINE; NUCLEAR MEDICINE; ORGANS; PATHOLOGICAL CHANGES; RADIOLOGY; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.